Arup R. Chakraborty

<i>SMARCA4</i> /BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer

Erica H. Bell, Arup R. Chakraborty, Xiaokui Mo et al. · Clinical Cancer Research · 2015 · 147 citations · Full text

Medicine, Molecular Genetics, Oncology +17

MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor

Arup R. Chakraborty, Robert W. Robey, Victoria Luchenko et al. · Blood · 2013 · 87 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Stanniocalcin-1 regulates endothelial gene expression and modulates transendothelial migration of leukocytes

Arup R. Chakraborty, Heddwen L. Brooks, Ping Zhang et al. · American Journal of Physiology-Renal Physiology · 2006 · 60 citations

Life Sciences, Cell Biology, Immunology +17

Histone deacetylase inhibitor‐mediated cell death is distinct from its global effect on chromatin

Victoria Luchenko, Thomas Litman, Arup R. Chakraborty et al. · Molecular Oncology · 2014 · 49 citations · Full text

Medicine, Oncology, Pharmacology +17

Loss of the proteins Bak and Bax prevents apoptosis mediated by histone deacetylase inhibitors

Caterina Ieranò, Arup R. Chakraborty, Alina Nicolae et al. · Cell Cycle · 2013 · 33 citations · Full text

Medicine, Oncology, Pharmacology +14